ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryHealthcareMedical LaboratoriesEpalingesNovigenix SA
Novigenix SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Novigenix is the development and application of precision medicine solutions, particularly in the field of cancer early detection and treatment, using liquid biopsy technologies and artificial intelligence (AI) based analysis platforms, such as the LITOSeek platform. The company focuses on researching and developing innovative approaches to cancer treatment, including the identification of new target molecules for drugs and the development of precision medicine approaches for personalized cancer treatment.

AI-generated
Offering

Products & services

Industry:Medical LaboratoriesMedical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Novigenix SA

✓ Offered3
LITOSeek™ platform
Liquid immuno-transcriptomics platform for blood RNA sequencing, multi-omics analysis, biomarker discovery, therapy response prediction, disease monitoring, and precise patient profiling in oncology.
Biomarker testing services
Biomarker services for biopharma and academic centres: ImmunoPD response markers, predictive biomarkers for response and resistance, mechanism-of-action and safety biomarkers, digital cytometry.
Translational medicine solutions
Translational medicine with LITOSeek™ for precise development of new therapeutics, clinical studies and workflows: response markers, resistance markers, mechanisms, safety biomarkers and digital cytometry.
Trust & reputation

ranQ Trust Score of Novigenix SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Novigenix SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Novigenix SA scores 89.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Novigenix SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Novigenix SA scores 70.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.71.44%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.70.04%
Qualifications+0.00

Novigenix SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

March 6, 2026Media
Novigenix spins-out AI-Powered Immune Intelligence pionneer
startupticker.ch
April 4, 2025Media
Novigenix obtains EUR 1.8 million EU grant to industrialize AI-powered liquid biopsy
startupticker.ch
October 3, 2024Media
EU funds AI-driven medical projects powered by Swiss startups
startupticker.ch
March 11, 2021Media
New appointments at life sciences startups
startupticker.ch
October 18, 2019Media
Fast progress for Novigenix
startupticker.ch
May 15, 2019Media
New appointees join executive positions to fuel growth
startupticker.ch

Knowledge

No knowledge articles yet

Once Novigenix SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Novigenix SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Novigenix SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Novigenix SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 3
1066 Epalinges

At a glance

Legal form
Corporation
UID
CHE-496.504.999
Founded
2014 · 12 years
Last commercial register change
July 20, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    NA
    Novigenix AI SA
    Epalinges
    AÀ
    ANABIOTEC, à Evergem, succursale de Epalinges (VD)
    Epalinges
    SN
    Swiss Nutrition and Health Foundation (SNHf)
    Epalinges
    GS
    Genesupport SA, succursale du canton de Vaud
    Epalinges
    LM
    LabPoint Medizinische Laboratorien AG
    Avenches
    UL
    Unilabs, Laboratoire d'analyses médicales SA, succursale de Coppet
    Coppet
    MS
    Medalis SA
    Renens Vd
    PS
    Polyanalytic S.A.
    Lausanne